Health

Firmenich Opens Culinary & SmartProteins® Innovation Hub in Singapore

GENEVA, May 3, 2021 /PRNewswire/ -- Firmenich, the world's largest privately owned fragrance and taste company, today announces the launch of its Culinary and SmartProteins® Innovation Center in Tuas,Singapore. The new center will serve as a regional R&D hub forAsia and a global center of experti...

2021-05-03 23:23 2351

Metavention Announces Initiation of Groundbreaking Multi-Organ Denervation Study

MINNEAPOLIS, May 4, 2021 /PRNewswire/ -- Metavention, Inc. announces the initiation of the MODUS Study (ACTRN12620000412932), to treat patients with both type 2 diabetes and hypertension using a catheter-based, minimally invasive approach. The first procedures in this study were successfully com...

2021-05-03 21:00 1691

Jacobio Announces FDA Approves IND Application to Develop KRAS G12C Inhibitor

BEIJING and SHANGHAI and BOSTON, May 2, 2021 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK) has announced  the U.S. Food and Drug Administration (FDA) has approved company's Investigational New Drug (IND) application to develop a KRAS G12C inhibitor. IND application to the National Medical Pro...

2021-05-03 09:30 4502

Revotek Deploys Its Bioink Technology to Research Institutes

CHENGDU, China, April 29, 2021 /PRNewswire/ -- Recently, Revotek Co., Ltd. ("Revotek"), a vertically integrated biotech company specialized in 3D bioprinting, and West China Hospital ofSichuan University, a leading research hospital inChina, have reached an agreement, in which the latter shall i...

2021-04-29 21:30 1716

Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report

Highlights: * Michael J. Fox Foundation grants Alterity $US495K for Parkinson's disease research evaluation * Strengthening profile at investment, scientific and clinical conferences * Dr David Stamler appointed Chief Executive Officer * Cash balance as at 31 March 2021 of A$32.8M MELBOURN...

2021-04-29 20:30 6189

I-Mab Announces Upcoming Participation at May Conferences

SHANGHAI and GAITHERSBURG, Md., April 29, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in May. ...

2021-04-29 20:00 3599

I-Mab Filed 2020 Annual Report on Form 20-F

SHANGHAI and GAITHERSBURG, Md., April 28, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Company has filed its annual report on Form 20...

2021-04-28 20:00 1988

GenScript Launches Research-Grade Lentiviral Vector Packaging Service

PISCATAWAY, N.J., April 28, 2021 /PRNewswire/ -- GenScript® , the world's leading reagents provider, announced today the launch of its Research Lentiviral Vector Packaging Service for cell lin...

2021-04-28 19:30 2917

Samsung Biologics Reports First Quarter 2021 Financial Results

* Q1'21 revenue of KRW 260.8 billion increased 26% compared to Q1'20. * Q1'21 operating profit of KRW 74.3 billion increased 19% compared to Q1'20. * Q1'21 operating margin held steady at 28%. * All manufacturing facilities remain fully operational, without any disruptions caused by the COV...

2021-04-28 16:37 4821

New Distribution Facility Expands Bushu Pharma's Gateway to Asia (GTA) Services

KAWAGOE, Japan, April 28, 2021 /PRNewswire/ -- Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") has established the Bushu Pharma Kazo Packaging Center located within the Kazo Pharmaceuticals Joint Distribution Center of Chuo Unyu Company ("Chuo Unyu") to carry out inspection, labeling, pac...

2021-04-28 14:00 1416

Amazfit T-Rex Pro in the Spotlight at Palm Beaches Spartan Sprint 5K Weekend

WEST PALM BEACH, Fla., April 27, 2021 /PRNewswire/ -- Amazfit , a global brand in the wearables market, celebrated its official role as Presenting Partner of theSpartan Sprint ™ in Palm Beaches, Fla. and introduced the Amazfit T-Rex Pro. Las...

2021-04-28 00:01 2107

TCI Co., Ltd. becomes Asia's first biotechnology company whose climate ambitions are validated by SBTi

TAIPEI, April 27, 2021 /PRNewswire/ -- TCI Co., Ltd. (8436. TWO), the leading nutraceutical ODM company, announced onApril 22nd that it is finally, after six months of review, recognized by the Science Based Targets Initiative (SBTi) as "committed" to aligning its actions to reduce greenhouse ...

2021-04-27 15:53 2874

Bushu Pharma's Collaboration with Suzuken Group Expands Services for Specialty Pharmaceuticals

KAWAGOE, Japan, April 27, 2021 /PRNewswire/ -- -Establishment of New Business Alliance and Facility to Provide Comprehensive Support for New Product Launches for Manufacturers Aiming to Enter Japan Market- Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") has entered into a business allian...

2021-04-27 14:00 2325

PharmAbcine to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting

DAEJEON, South Korea, April 26, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company will present an e-poster featuring non-clinical data of PMC-403 at the Association for ...

2021-04-26 20:00 1851

I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulcerative Colitis

SHANGHAI and GAITHERSBURG, Md., April 26, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced positive topline results from its regional multi-center...

2021-04-26 19:00 2163

Peijia Medical's TaurusOne® Transcatheter Aortic Valve Replacement System Approved for Commercialization

SUZHOU, China, April 24, 2021 /PRNewswire/ -- A new interventional solution from China for structural heart disease is about to be launched onto the market. Recently, TaurusOne® Transcatheter Aortic Valve Replacement System (hereinafter referred to as "TaurusOne®") developed by Peijia Medical (Suz...

2021-04-25 08:53 3239

Ronovo Surgical Completes Series A Financing, Aims to Transform Surgery with Innovations Focused on Simplicity, Precision and Intelligence.

SHANGHAI, April 23, 2021 /PRNewswire/ -- Ronovo Surgical, an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery to address the tremendous needs of the Chinese surgical market, recently announced successful closing of Series A financing. Developed by renow...

2021-04-23 22:00 3455

Jolly Good and Teijin Pharma Form a Partnership to Develop VR Digital Therapeutics for Depression

TOKYO, April 23, 2021 /PRNewswire/ -- Jolly Good Inc. ("Jolly Good") and Teijin Pharma Ltd. ("Teijin Pharma") have signed a business partnership agreement to develop VR digital therapeutics ("VR DTx") for Major Depressive Disorder (MDD). Together, they will promote the development of VR DTx for d...

2021-04-23 21:00 3086

JRSIS Health Care Corporation (OTCQX: JRSS) Announces Financial Results for the 2020 Fiscal Year

HARBIN, China, April 22, 2021 /PRNewswire/ -- JRSIS Health Care Corporation. (OTCQX: JRSS)("JRSS" or the "Company") today announced its financial results for the fiscal year endedDecember 31, 2020. The Company's Annual Report on Form 10-K containing its audited consolidated financial statements...

2021-04-23 02:00 3717

Vaccines: More cooperation, less speculation

BEIJING, April 22, 2021 /PRNewswire/ -- A news report by China.org.cn on China's attitude towards China-US trade friction: Recently, there have been media reports saying that a Chinese official "admitted" low effectiveness of the country's COVID-19 vaccines. Given that many countries have alread...

2021-04-22 21:00 2011
1 ... 294295296297298299300 ... 313

Week's Top Stories